Onderneming Dyadic International, Inc. Other OTC
Aandelen
US26745T1016
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Industrial Enzymes and Other Proteins
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -1,07% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Netherlands
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -1,07% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 01-01-79 |
Ping Rawson
DFI | Director of Finance/CFO | 48 | 01-06-16 |
Joseph Hazelton
COO | Chief Operating Officer | 48 | 09-11-21 |
Ronen Tchelet
CTO | Chief Tech/Sci/R&D Officer | 66 | 06-05-14 |
Doug Pace
PRN | Corporate Officer/Principal | - | 09-10-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 01-01-79 |
Jack Kaye
BRD | Director/Board Member | 80 | 01-05-15 |
Michael Tarnok
BRD | Director/Board Member | 69 | 12-06-14 |
Patrick Lucy
CHM | Chairman | 56 | 08-01-21 |
Seth Herbst
BRD | Director/Board Member | 66 | 20-06-08 |
Barry Buckland
BRD | Director/Board Member | 76 | 03-01-18 |
Arindam Bose
BRD | Director/Board Member | 71 | 15-08-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 41 490 316 | 20 348 574 ( 49,04 %) | 12 253 502 ( 29,53 %) | 49,04 % |
Bedrijfsgegevens
Dyadic International, Inc.
1044 North US Highway One Suite 201
33477-5094, Jupiter
+
http://www.dyadic.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,03% | 48,16 mld. | |
-0,10% | 41,73 mld. | |
+43,45% | 41,03 mld. | |
-5,26% | 28,77 mld. | |
+11,48% | 25,59 mld. | |
-22,74% | 18,96 mld. | |
+9,06% | 12,92 mld. | |
+30,01% | 12,03 mld. | |
-1,51% | 11,77 mld. |